These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2177146)

  • 1. Some cellular and molecular characteristics of high and low tumorigenicity variants of polyoma-virus transformed cells.
    Berko-Flint Y; Fridman WH; Grossman-Atlas E; Kimchi N; Ben-Baruch AL; Moss S; Teillaud JL; Witz IP; Ran M
    Mol Immunol; 1990 Dec; 27(12):1219-28. PubMed ID: 2177146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo acquisition of Fc gamma RII expression on polyoma virus-transformed cells derived from tumors of long latency.
    Ran M; Katz B; Kimchi N; Halachmi E; Teillaud JL; Even J; Berko-Flint Y; Atlas E; Fridman WH; Witz IP
    Cancer Res; 1991 Jan; 51(2):612-8. PubMed ID: 1845956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential tumorigenicity of 3T3 cells transformed in vitro with polyoma virus and in vivo selection for high tumorigenicity.
    Halachmi E; Witz IP
    Cancer Res; 1989 May; 49(9):2383-9. PubMed ID: 2539901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The murine Fc-gamma (Fc gamma) receptor type II B1 is a tumorigenicity-enhancing factor in polyoma-virus-transformed 3T3 cells.
    Zusman T; Gohar O; Eliassi H; Avivi Y; Lisansky E; Sautes C; Even J; Bonnerot C; Fridman WH; Witz IP; Ran M
    Int J Cancer; 1996 Jan; 65(2):221-9. PubMed ID: 8567121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic properties of 3T3 cells transformed in vitro with polyoma virus and passaged once in syngeneic animals.
    Langer AB; Emmanuel N; Even J; Fridman WH; Gohar O; Gonen B; Katz BZ; Ran M; Smorodinsky NI; Witz IP
    Immunobiology; 1992 Aug; 185(2-4):281-91. PubMed ID: 1333442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of Fc gamma receptor in cancer patients and tumor bearing mice.
    Ran M; Teillaud JL; Fridman WH; Frenkel H; Halachmi E; Katz B; Gips M; Shlomo Y; Barzilay J; Witz IP
    Mol Immunol; 1988 Nov; 25(11):1159-67. PubMed ID: 2851735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vivo enhancement of IL-1alpha receptor expression on polyoma virus transformed tumor derived cells.
    Arons E; Zusman T; Ran M
    Int J Oncol; 1998 Jun; 12(6):1379-83. PubMed ID: 9592203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T antigens' role in polyomavirus transformation: c-myc but not c-fos or c-jun expression is a target for middle T.
    Rameh LE; Armelin MC
    Oncogene; 1991 Jun; 6(6):1049-56. PubMed ID: 1648700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperation of p53 and polyoma virus middle T antigen in the transformation of primary rat embryo fibroblasts.
    Reihsaus E; Kraiss S; Barnekow A; Montenarh M
    Exp Cell Res; 1992 Mar; 199(1):10-8. PubMed ID: 1735451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrupting the early region of polyoma virus DNA enhances tumorigenicity.
    Israel MA; Simmons DT; Hourihan SL; Rowe WP; Martin MA
    Proc Natl Acad Sci U S A; 1979 Aug; 76(8):3713-6. PubMed ID: 226975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung colonization by and heparanase activity in in vitro transformed 3T3 cells rendered highly tumorigenic by an in vivo passage.
    Katz BZ; Ishai-Michaeli R; Zusman T; Vlodavsky I; Witz IP
    Invasion Metastasis; 1994-1995; 14(1-6):276-89. PubMed ID: 7657521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell transformation mediated by chromosomal deoxyribonucleic acid of polyoma virus-transformed cells.
    Della Valle G; Fenton RG; Basilico C
    Mol Cell Biol; 1981 May; 1(5):418-25. PubMed ID: 6100965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyoma-induced neoplasms of the mouse adrenal medulla. Characterization of the tumors and establishment of cell lines.
    Tischler AS; Freund R; Carroll J; Cahill AL; Perlman RL; Alroy J; Riseberg JC
    Lab Invest; 1993 May; 68(5):541-9. PubMed ID: 8098784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended life span and tumorigenicity of nonestablished mouse connective tissue cells transformed by the fos oncogene of FBR-MuSV.
    Jenuwein T; Müller D; Curran T; Müller R
    Cell; 1985 Jun; 41(2):629-37. PubMed ID: 2985286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformation of rat embryo fibroblasts by cloned polyoma virus DNA fragments containing only part of the early region.
    Hassell JA; Topp WC; Rifkin DB; Moreau PE
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):3978-82. PubMed ID: 6254006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of transformed clones obtained by coinfections with hr-t and ts-a mutants of polyoma virus.
    Fluck MM; Shaikh R; Benjamin TL
    Virology; 1983 Oct; 130(1):29-43. PubMed ID: 6314651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyoma virus middle T gene can trigger malignant transformation of early passage rodent cells.
    Spandidos DA; Riggio M
    J Gen Virol; 1986 Apr; 67 ( Pt 4)():793-9. PubMed ID: 3007666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro exposure of polyoma-virus-transformed cells to laminin augments their in vivo malignancy phenotype.
    Katz BZ; Witz IP
    Invasion Metastasis; 1993; 13(4):185-94. PubMed ID: 8034440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Karyotypic instability and viral integration in polyoma virus-induced mouse salivary gland tumors.
    Sandros J; Stenman G
    Genes Chromosomes Cancer; 1990 Jul; 2(2):109-15. PubMed ID: 2177643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation by polyoma virus middle T antigen.
    Courtneidge SA
    Cancer Surv; 1986; 5(2):173-82. PubMed ID: 2430702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.